Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional)
Funder
National Institutes of Health
LOI Deadline
LOI Required
Recommended, but not required
Application Deadline
Maximum Project Duration
3 years
Research Focus Areas
Substance Use/Misuse/Addiction
Cognitive
Clinical
Behavioral Health Integration/Collaborative Care
Behavioral and Systems
Alcohol
Research Methods
Randomized Control Trials (RCT)
Description
The purpose of this notice of funding opportunity (NOFO) is to encourage research grant applications on the development and testing of behavioral and integrative treatments for drug and alcohol use, misuse, and dependence. This NOFO reaffirms the continued commitment of the National Institute on Drug Abuse (NIDA) to major programs of research on behavioral and integrative treatments. The term "behavioral treatment" is used in a broad sense and includes but is not limited to psychotherapies, cognitive, relapse prevention, remediative, rehabilitative, skills training, counseling, family, and exercise therapies. Screening, brief, computerized, adherence, prevention interventions for HIV risk behaviors, and interventions that target therapist training and fidelity are included. Integrative refers to combinations with other treatments, including pharmacotherapies or other complementary approaches. The development and testing of putative targets and mechanisms of behavior change, as well as the use and development of valid and reliable assessment tools are crucial to the three stages of treatment research supported under this initiative (Review the 3 stages in the FOA).